Generic Name:

Fosaprepitant Dimeglumine 150mg

Storage Condition:

Store in a refrigerator (2° - 8°C). Do not freeze.

Packing:

1 Vial

Mfg / Mkd By:

Glenmark Pharmaceuticals Ltd

Doses:


Therapeutic Use:

Chemotherapy induce nausea and vomiting

Description:

Introduction :

Dolphin Pharmaceutical is a leading Fosaprepitant Dimeglumine supplier from India, based in Surat, Gujarat, specializing in the global supply of high-quality specialty medicines. We serve pharmaceutical importers, distributors, hospitals, and healthcare organizations worldwide with quality-assured Fosaprepitant Dimeglumine.

Fosaprepitant Dimeglumine is primarily used for the treatment of chemotherapy induce nausea and vomiting, under the supervision of qualified healthcare professionals. Dolphin Pharmaceutical is committed to providing authentic medicines, competitive pricing, complete support, global healthcare requirements.

Aprecap 150 mg Injection

Aprecap (Fosaprepitant Dimeglumine) Injection contains fosaprepitant dimeglumine, an antiemetic medicine belonging to the neurokinin-1 (NK1) receptor antagonist class. It is used to prevent acute and delayed nausea and vomiting associated with highly or moderately emetogenic chemotherapy, usually as part of a combination antiemetic regimen. Manufacturer: Glenmark Pharmaceuticals Ltd. Country of origin: India.

Product Introduction

Fosaprepitant Dimeglumine 150 mg Injection is a prescription antiemetic medicine used to prevent nausea and vomiting associated with chemotherapy. It is particularly useful for controlling both the early and delayed phases of chemotherapy-induced nausea and vomiting.

Fosaprepitant Dimeglumine Injection is administered by a qualified healthcare professional under medical supervision. The dose and timing will be determined by your doctor based on your chemotherapy regimen and individual needs. Do not self-administer this medicine or change the prescribed dose. Your doctor may recommend regular monitoring, including liver function tests, during treatment.

Common side effects may include fatigue, headache, decreased appetite, constipation, indigestion, weakness, diarrhea, and hiccups. Some patients may experience dizziness or drowsiness. Avoid driving, operating machinery, or performing activities requiring mental alertness if you feel affected.

Uses of Fosaprepitant Dimeglumine 150 mg Injection

• Prevention of nausea and vomiting caused by chemotherapy

Benefits of Fosaprepitant Dimeglumine Injection

Chemotherapy-induced nausea and vomiting: Chemotherapy can cause nausea and vomiting, which may lead to dehydration, poor nutritional intake, weakness, and reduced quality of life. Fosaprepitant Dimeglumine 150 mg Injection helps prevent these symptoms by blocking the action of neurokinin-1 (NK1), a chemical signaling pathway involved in chemotherapy-induced vomiting. By controlling both acute and delayed nausea and vomiting, it can improve patient comfort and help patients continue their chemotherapy treatment as planned.

Side Effects of Fosaprepitant Dimeglumine 150 mg Injection

Most side effects are mild and may improve as the body adjusts to treatment. Consult your doctor if any side effect persists, worsens, or causes concern.

Commonly reported side effects include:

• Indigestion

• Fatigue

• Weakness

• Diarrhea

• Decreased white blood cell count (neutropenia)

• Anemia (low red blood cell count)

• Peripheral neuropathy (tingling or numbness in the hands and feet)

• Decreased lymphocyte count

• Urinary tract infection

• Pain in the extremities

• Headache

• Decreased appetite

• Constipation

• Hiccups

How Aprecap Fosaprepitant Dimeglumine Works

Aprecap 150 mg Injection contains fosaprepitant, an antiemetic medicine. It is converted in the body to aprepitant and works by blocking neurokinin-1 (NK1) receptors in the brain.

These receptors are involved in the signaling pathway that triggers vomiting during and after chemotherapy. By blocking NK1 receptor activity, Aprecap helps prevent both the immediate and delayed phases of chemotherapy-induced nausea and vomiting.

Global Presence :

Dolphin Pharmaceutical is an India-based manufacturer and exporter of finished pharmaceutical formulations and medical supplies. Our portfolio includes oncology, anti-HIV, diabetic, antihypertensive, hormonal medicines, ophthalmic eye drops, along with fibrin sealant kits, blood collection bags, hospital consumables and all surgical products.

We provide fast delivery within 10–12 days to over 25 countries as following:

• Caribbean: Antigua and Barbuda, The Bahamas, Barbados, Dominica, Dominican Republic, Grenada, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago

• Africa: Nigeria, Kenya, Tunisia, Algeria, Ghana, Senegal, Somalia, Morocco.

• Asia: Indonesia, Vietnam, Thailand, Malaysia, Cambodia , Timor-Leste, the Philippines, Singapore.

All products are manufactured in compliance with GMP standards and WHO guidelines, ensuring quality and regulatory adherence. We supply reliable and cost-effective healthcare products to international markets, supporting bulk and customized requirements.




Our Other Products

View All
Apretero (Aprepitant)

Apretero (Aprepitant) 125 mg + 80 mg

Generic Name: Aprepitant 125/80

Capsule
Packaging:1 kit
Mfg / Mfd By:Hetero Healthcare Ltd
Storage Condition:Store below 30°C
Therapeutic Use:
Chemotherapy induce nausea and vomiting
Apristar (Aprepitant)

Apristar (Aprepitant) 125 mg / 80 mg

Generic Name: Aprepitant 125/80

Capsule
Mfg / Mfd By:Lupin Ltd
Storage Condition:Store below 30°C
Therapeutic Use:
Chemotherapy induce nausea and vomiting
Fosup (Fosaprepitant Dimeglumine)

Fosup (Fosaprepitant Dimeglumine) 150 mg

Generic Name: Fosaprepitant Dimeglumine 150mg

Injection
Packaging:150 mg Vial
Mfg / Mfd By:Zydus Lifesciences Limited
Storage Condition:Store in a refrigerator (2° - 8°C). Do not freeze.
Therapeutic Use:
Chemotherapy induce nausea and vomiting